| Research directions of the laboratory: | - Development and application of the synthesis/production of therapeutically and industrially important recombinant proteins and enzymes in green plant leaves;
- Development of ways to obtain high biomass, bioenergy, and biofuel production from green algae.
|
| Main scientific achievements: | - For the first time in the world, a cocktail vaccine candidate consisting of RBD (Receptor Binding Domain) and Nucleocapsid (N) proteins of SARS-CoV-2 virus against COVID-19 has been synthesized in sufficient quantities for commercialization in the Nicotiana benthamiana plant and preclinical studies have been completed. Meanwhile, as a potential therapeutic agent, recombinant human angiotensin-converting enzyme 2 (AGE2) variants with potent anti-SARS-CoV-2 activity have been successfully synthesized in Nicotiana benthamiana in quantities sufficient for commercialization, and preclinical studies have been completed;
- For the first time, the presence of glycoproteins consisting of a sialic acid residue linked to 1,4-galactose in carbon dioxide-fixing green algal organisms was identified;
- For the first time, the enzyme phosphoglycolate phosphatase, the main enzyme of photorespiration, was purified from the algae Clomidomanad reinhardtii and its nucleotide and amino acid sequences were read.
|
